Median expression for both ARID5A and FOXC1 showed an upward trend in carriers versus noncarriers, albeit it did not reach statistical significance (fig.
← all excerpts
The human genetic variant rs6190 unveils Foxc1 and Arid5a as novel prometabolic targets of the glucocorticoid receptor in muscle.
1
—
—